158 related articles for article (PubMed ID: 3793498)
1. The use of radionuclides for tumor therapy.
Fawwaz RA; Wang TS; Srivastava SC; Hardy MA
Int J Rad Appl Instrum B; 1986; 13(4):429-36. PubMed ID: 3793498
[TBL] [Abstract][Full Text] [Related]
2. Radioimmunotherapy of malignancy using antibody targeted radionuclides.
Cobb LM; Humm JL
Br J Cancer; 1986 Dec; 54(6):863-70. PubMed ID: 3542006
[TBL] [Abstract][Full Text] [Related]
3. Future role of radiolabeled monoclonal antibodies in oncological diagnosis and therapy.
Goldenberg DM
Semin Nucl Med; 1989 Oct; 19(4):332-9. PubMed ID: 2678484
[TBL] [Abstract][Full Text] [Related]
4. Lymphoma, melanoma, colon cancer: diagnosis and treatment with radiolabeled monoclonal antibodies. The 1986 Eugene P. Pendergrass New Horizons Lecture.
Larson SM
Radiology; 1987 Nov; 165(2):297-304. PubMed ID: 3498971
[TBL] [Abstract][Full Text] [Related]
5. Targeting of human glioma xenografts in vivo utilizing radiolabeled antibodies.
Williams JA; Wessels BW; Wharam MD; Order SE; Wanek PM; Poggenburg JK; Klein JL
Int J Radiat Oncol Biol Phys; 1990 Jun; 18(6):1367-75. PubMed ID: 2370186
[TBL] [Abstract][Full Text] [Related]
6. Antibody-radionuclide conjugates for cancer therapy: historical considerations and new trends.
Steiner M; Neri D
Clin Cancer Res; 2011 Oct; 17(20):6406-16. PubMed ID: 22003068
[TBL] [Abstract][Full Text] [Related]
7. Contributions of nuclear medicine to the therapy of malignant tumors.
Feinendegen LE
Strahlenther Onkol; 1991 Nov; 167(11):619-27. PubMed ID: 1962275
[TBL] [Abstract][Full Text] [Related]
8. Biodistribution of 131I-, 186Re-, 177Lu-, and 88Y-labeled hLL2 (Epratuzumab) in nude mice with CD22-positive lymphoma.
Postema EJ; Frielink C; Oyen WJ; Raemaekers JM; Goldenberg DM; Corstens FH; Boerman OC
Cancer Biother Radiopharm; 2003 Aug; 18(4):525-33. PubMed ID: 14503946
[TBL] [Abstract][Full Text] [Related]
9. Prospects for monoclonal antibody therapy of leukemia and lymphoma.
Badger CC; Bernstein ID
Cancer; 1986 Jul; 58(2 Suppl):584-9. PubMed ID: 3521840
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin.
Koppe MJ; Bleichrodt RP; Soede AC; Verhofstad AA; Goldenberg DM; Oyen WJ; Boerman OC
J Nucl Med; 2004 Jul; 45(7):1224-32. PubMed ID: 15235070
[TBL] [Abstract][Full Text] [Related]
11. Radioimmunotherapy of athymic mice bearing human colon carcinomas with monoclonal antibody B72.3: histological and autoradiographic study of effects on tumors and normal organs.
Esteban JM; Schlom J; Mornex F; Colcher D
Eur J Cancer Clin Oncol; 1987 Jun; 23(6):643-55. PubMed ID: 2820742
[TBL] [Abstract][Full Text] [Related]
12. [Perspectives in the use of monoclonal antibodies in the therapy of neoplastic diseases].
Emmrich F
Onkologie; 1987 Jun; 10(3):121-4. PubMed ID: 3306530
[TBL] [Abstract][Full Text] [Related]
13. Pretargeting: taking an alternate route for localizing radionuclides.
Sharkey RM; Chang CH; Rossi EA; McBride WJ; Goldenberg DM
Tumour Biol; 2012 Jun; 33(3):591-600. PubMed ID: 22396041
[TBL] [Abstract][Full Text] [Related]
14. Radionuclide therapy of cancer with radiolabeled antibodies.
Boerman OC; Koppe MJ; Postema EJ; Corstens FH; Oyen WJ
Anticancer Agents Med Chem; 2007 May; 7(3):335-43. PubMed ID: 17504159
[TBL] [Abstract][Full Text] [Related]
15. Radiolabeled monoclonal anti-tumor antibodies in diagnosis and therapy.
Larson SM
J Nucl Med; 1985 May; 26(5):538-45. PubMed ID: 3989608
[TBL] [Abstract][Full Text] [Related]
16. Radionuclide therapy revisited.
Hoefnagel CA
Eur J Nucl Med; 1991; 18(6):408-31. PubMed ID: 1879447
[TBL] [Abstract][Full Text] [Related]
17. Radiation absorbed dose estimates at the cellular level for some electron-emitting radionuclides for radioimmunotherapy.
Jungerman JA; Yu KH; Zanelli CI
Int J Appl Radiat Isot; 1984 Sep; 35(9):883-8. PubMed ID: 6480148
[TBL] [Abstract][Full Text] [Related]
18. Optimizing radioimmunotherapy by matching dose distribution with tumor structure using 3D reconstructions of serial images.
Flynn AA; Pedley RB; Green AJ; Boxer GM; Boden R; Begent RH
Cancer Biother Radiopharm; 2001 Oct; 16(5):391-400. PubMed ID: 11776756
[TBL] [Abstract][Full Text] [Related]
19. [Immunotargeting of tumors: state of the art and prospects in 2000].
Pèlegrin A; Xavier F; Barbet J; Bartholeyns J; Baty D; Buchegger F; Chatal JF; Dufief F; Gurreau D; Gruaz-Guyon A; Lamotte D; Leserman L; Mach JP; Robert B; Saccavini JC; Teillaud JL; Teulon I
Bull Cancer; 2000 Nov; 87(11):777-91. PubMed ID: 11125287
[TBL] [Abstract][Full Text] [Related]
20. Animal models for radiolabeled monoclonal antibodies in cancer research.
Aas M; Fjeld JG
Acta Oncol; 1993; 32(7-8):819-24. PubMed ID: 8305231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
